Semler Scientific Stock News

With the market trading near all-time highs, undervalued healthcare stocks offer a compelling opportunity. Fundamentally, the sector could benefit from a rotation in the innovation ecosystem.

SANTA CLARA, Calif. , Feb. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev

The recent sell-off in tech stocks has left many high-quality names trading at sizable discounts. For long-term investors, this presents an intriguing opportunity to position one's portfolio for the n

Semler Scientific, Inc. (NASDAQ:SMLR ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Doug Murphy-Chutorian – Chief Executive Officer Renae Cormier – Chief Finan

Semler Scientific's 1H 2023 was surprisingly strong, with record high fixed-fee and variable-fee revenues. Semler's strong financial performance stands in stark contrast to its stock price, which has

SANTA CLARA, Calif. , Aug. 31, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev

Start Time: 16:30 January 1, 0000 4:49 PM ET Semler Scientific, Inc. (NASDAQ:SMLR ) Q2 2023 Earnings Conference Call August 10, 2023, 16:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO Re

SANTA CLARA, Calif. , July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev

Semler Scientific, Inc. (NASDAQ:SMLR ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Douglas Murphy-Chutorian - Interim Chief Executive Officer Renae Cormier - Head of

Semler Scientific, Inc. (NASDAQ:SMLR ) Q4 2022 Results Conference Call March 21, 2023 4:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary Wayne Pan - New CEO Renae Corm

The recent drastic drop in stock price is grossly exaggerated. Value proposition of QuantaFlo, Semler's main product, remains intact.

The CMS advanced notice for Medicare advantage for the year 2024 removed the PAD HCC code QuantaFlo uses. This could negatively impact QuantaFlo's usage. Semler's stock crashed as a result.

Semler Scientific Inc. (SMLR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earni

The medical diagnostic company plunged after it gave soft guidance for the fourth quarter.

Semler Scientific, Inc. (NASDAQ:SMLR ) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary Dennis Rosenberg - Chief Ma